Navigation Links
Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
Date:9/8/2010

ALEXANDRIA, Va., Sept. 8 /PRNewswire/ -- Oxford Finance Corporation (Oxford), a subsidiary of Sumitomo Corporation, is pleased to announce the addition of Dr. Killu Sanborn to its Business Development group. As director, Business Development, she is responsible for originating loan facilities for life science companies, primarily in western North America.

She has over 20 years of experience as a lender and equity investor, banker, executive and entrepreneur. Her previous positions include managing director at Hercules Technology Growth Capital, senior vice president of Comerica Bank, principal/fund manager at IngleWood Ventures, director of Technology Commercialization at Stratagene and vice president of Business Development at Phenogenex. Over the years, Dr. Sanborn has also advised entrepreneurial boards and management teams on operational, financial and strategic matters.

"Dr. Sanborn is well-known and highly respected in the life science arena," said Christopher A. Herr, managing director for Oxford Finance Corporation. She brings with her a deep understanding of the financing needs of life science companies and will be a great asset to our Business Development team."

About Oxford Finance Corporation

A subsidiary of Sumitomo Corporation, Oxford is a specialty finance firm that provides senior secured loans to public and private life science and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $1.5 billion in loans, with lines of credit ranging from $500 thousand to $40 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.


'/>"/>
SOURCE Oxford Finance Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
2. Oxford BioTherapeutics Appoints Michael Moore as Chairman
3. Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
4. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
5. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
6. Bavarian Nordics Case Against Oxford BioMedica
7. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
8. Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
9. Merrimack Pharmaceuticals Promotes William Sullivan to Vice President of Finance
10. Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement
11. Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick, Maryland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... ... May 20, 2016 , ... Korean researchers say Manumycin A triggers ... a new way to treat the disease. Surviving Mesothelioma has just posted an article ... from several Korean institutions based their mesothelioma study on the fact the Manumycin A, ...
(Date:5/19/2016)... , May 19, 2016 There ... fully recover given the relentless pressures in pricing and ... in the investors circle though - numerous opportunities are ... of today,s session, ActiveWallSt.com,s presents four names in this ... Vitae Pharmaceuticals Inc. (NASDAQ: VTAE ), Anthera ...
(Date:5/18/2016)... ... ... Tech Coast Angels (TCA) today announced that the Angel Capital Association ... Summit last week in Philadelphia. , The award recognizes the single-most ingenious ... is the highest honor available for an early-stage company to receive from the Angel ...
(Date:5/18/2016)... ... May 18, 2016 , ... Every day, more than 5,400 ... complications.* Costing more than $56 billion in direct costs annually, asthma remains a ... many, the suffering associated with uncontrolled asthma can be overwhelmingly disproportionate and better ...
Breaking Biology Technology:
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):